Melatonin profile and its relation to circadian rhythm sleep disorders in Angelman syndrome patients

Sleep Medicine

Volumn 13, Issue 9, 2012, Pages 1164-1170

  Takaesu, Yoshikazu ^a   Komada, Yoko ^a,b   Inoue, Yuichi ^a,b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

Author keywords

Angelman syndrome; Circadian rhythm sleep disorder; Melatonin; Neurodevelopmental disorder; Sleep logs

Indexed keywords

MELATONIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HAPPY PUPPET SYNDROME; HORMONE DETERMINATION; HUMAN; MALE; MELATONIN BLOOD LEVEL; NIGHT; PRIORITY JOURNAL; SCHOOL CHILD; SLEEP DISORDER; SLEEP PATTERN; SLEEP WAKING CYCLE; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANGELMAN SYNDROME; CASE-CONTROL STUDIES; CHILD; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MELATONIN; SLEEP DISORDERS, CIRCADIAN RHYTHM; YOUNG ADULT;

EID: 84867476272     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2012.06.015     Document Type: Article

References (36)

1. Clayton-Smith J. Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals. Am J Med Genet 1993, 46:12-15.
2. Didden R., Korzilius H., Duker P., Curfs L. Communicative functioning in individuals with Angelman syndrome: a comparative study. Disabil Rehabil 2004, 26:1263-1267.
3. Didden R., Korzilius H., Smits M.G., Curfs L.M. Sleep problems in individuals with Angelman syndrome. Am J Ment Retard 2004, 109:275-284.
4. Smith A., Wiles C., Haan E., McGill J., Wallace G., Dixon J., et al. Clinical features in 27 patients with Angelman syndrome resulting from DNA deletion. J Med Genet 1996, 33:107-112.
5. Summers J.A., Lynch P.S., Harris J.C., Burke J.C., Allison D.B., Sandler L. A combined behavioral/pharmacological treatment of sleep-wake schedule disorder in Angelman syndrome. J Dev Behav Pediatr 1992, 13:284-287.
6. Phillips L., Appleton R.E. Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Dev Med Child Neurol 2004, 46:771-775.
7. Wagner D.R. Disorders of the circadian sleep-wake cycle. Neurol Clin 1996, 14:651-670.
8. Wagner D.R. Circadian Rhythm Sleep Disorders. Curr Treat Options Neurol 1999, 1:299-308.
9. Claustrat B., Brun J., Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005, 9:11-24.
10. Sajith S.G., Clarke D. Melatonin and sleep disorders associated with intellectual disability: a clinical review. J Intellectl Disabil Res 2007, 51:2-13.
11. Zhdanova I.V., Wurtman R.J., Wagstaff J. Effects of a low dose of melatonin on sleep in children with Angelman syndrome. J Pediatr Endocrinol Metab 1999, 12:57-67.
12. Braam W., Didden R., Smits M.G., Curfs L.M. Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial. J Child Neurol 2008, 23:649-654.
13. Wright K.P., Myers B.L., Plenzler S.C., Drake C.L., Badia P. Acute effects of bright light and caffeine on nighttime melatonin and temperature levels in women taking and not taking oral contraceptives. Brain Res 2000, 873:310-317.
14. Djeridane Y., Touitou Y. Chronic diazepam administration differentially affects melatonin synthesis in rat pineal and Harderian glands. Psychopharmacology 2001, 154:403-407.
15. Hartter S., Grozinger M., Weigmann H., Roschke J., Hiemke C. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther 2000, 67:1-6.
16. Bojkowski C.J., Aldhous M.E., English J., Franey C., Poulton A.L., Skene D.J., et al. Suppression of nocturnal plasma melatonin and 6-sulphatoxymelatonin by bright and dim light in man. Horm Metab Res 1987, 19:437-440.
17. Sack R.L., Auckley D., Auger R.R., Carskadon M.A., Wright K.P., Vitiello M.V., et al. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review. Sleep 2007, 30:1484-1501.
18. Martinez D., Lenz Mdo C. Circadian rhythm sleep disorders. Indian J Med Res 2010, 131:141-149.
19. Cavallo A. Plasma melatonin rhythm in normal puberty: interactions of age and pubertal stages. Neuroendocrinology 1992, 55:372-379.
20. Monteleone P., Tortorella A., Borriello R., Natale M., Cassandro P., Maj M. Suppression of nocturnal plasma melatonin levels by evening administration of sodium valproate in healthy humans. Biol Psychiatry 1997, 41:336-341.
21. Hashimoto S., Nakamura K., Honma S., Honma K. Free-running of plasma melatonin rhythm prior to full manifestation of a non-24 hour sleep-wake syndrome. Psychiatry Clin Neurosci 1998, 52:264-265.
22. Hashimoto S., Nakamura K., Honma S., Honma K. Free-running circadian rhythm of melatonin in a sighted man despite a 24-hour sleep pattern: a non-24-hour circadian syndrome. Psychiatry Clin Neurosci 1997, 51:109-114.
23. Smith J.C. Angelman syndrome: evolution of the phenotype in adolescents and adults. Dev Med Child Neurol 2001, 43:476-480.
24. Waldhauser F., Weiszenbacher G., Tatzer E., Gisinger B., Waldhauser M., Schemper M., et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 1988, 66:648-652.
25. Lehman N.L. The ubiquitin proteasome system in neuropathology. Acta Neuropathol 2009, 118:329-347.
26. Wu Y., Bolduc F.V., Bell K., Tully T., Fang Y., Sehgal A., et al. A Drosophila model for Angelman syndrome. Proc Natl Acad Sci USA 2008, 105:12399-12404.
27. Jan M.M. Melatonin for the treatment of handicapped children with severe sleep disorders. Pediatr Neurol 2000, 23:229-232.
28. Pillar G., Shahar E., Peled N., Ravid S., Lavie P., Etzioni A. Melatonin improves sleep-wake patterns in psychomotor retarded children. Pediatr Neurol 2000, 23:225-228.
29. Miyamoto A., Oki J., Takahashi S., Okuno A. Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome. Brain Dev 1999, 21:59-62.
30. Makedonski K., Abuhatzira L., Kaufman Y., Razin A., Shemer R. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum Mol Genet 2005, 14:1049-1058.
31. Laakso M.L., Lindblom N., Leinonen L., Kaski M. Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study. Sleep Med 2007, 8:222-239.
32. Zee P.C., Vitiello M.V. Circadian rhythm sleep disorder: irregular sleep wake rhythm type. Sleep Med Clin 2009, 4:213-218.
33. Nakamura K., Hashimoto S., Honma S., Honma K., Tagawa Y. A sighted man with non-24-hour sleep-wake syndrome shows damped plasma melatonin rhythm. Psychiatry Clin Neurosci 1997, 51:115-119.
34. Okawa M., Uchiyama M. Circadian rhythm sleep disorders: characteristics and entrainment pathology in delayed sleep phase and non-24-h sleep-wake syndrome. Sleep Med Rev 2007, 11:485-496.
35. Pandi-Perumal S.R., Smits M., Spence W., Srinivasan V., Cardinali D.P., Lowe A.D., et al. Dim light melatonin onset (DLMO): a tool for the analysis of circadian phase in human sleep and chronobiological disorders. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1-11.
36. Lewy A.J., Emens J., Jackman A., Yuhas K. Circadian uses of melatonin in humans. Chronobiol Int 2006, 23:403-412.